The scale is meant to better quantify how clusters of symptoms impact patients’ quality of life. Investigators have developed a new scale they say can help providers and caregivers better understand ...
Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results